Literature DB >> 2477484

Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.

M J Irwin1, W R Heath, L A Sherman.   

Abstract

As compared with the vigorous T cell response normally observed against allogeneic MHC molecules, T cells recognize xenogeneic MHC molecules poorly. To define structural features of the MHC molecule important for such species-specific recognition, HLA-A2(A2)-specific murine CTL were examined for their recognition of transfected cell lines expressing the class I molecules A2 or A2/H-2Kb(A2/Kb). A2/Kb is a chimeric molecule consisting of the alpha 1 and alpha 2 domains of A2 and the alpha 3, transmembrane, and cytoplasmic regions of Kb. The majority of CTL clones showed enhanced recognition of transfected cell lines expressing this chimeric molecule. Enhanced recognition was shown to correlate with sensitivity of the CTL clones to inhibition by anti-CD8 antibody. These results suggested that CD8 may interact with class I in a species-specific manner, and that suboptimal CD8 interaction with the alpha 3 domain of xenogeneic molecules may be an important contribution to poor xenoreactivity. This conclusion was supported by the capacity of A2/Kb, but not A2 human cell transfectants, to induce a primary in vitro CTL xenoresponse specific for A2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477484      PMCID: PMC2189481          DOI: 10.1084/jem.170.4.1091

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.

Authors:  F Emmrich; U Strittmatter; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.

Authors:  B H Koller; H T Orr
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

3.  H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.

Authors:  J L Maryanski; R S Accolla; B Jordan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes.

Authors:  J Gabert; C Langlet; R Zamoyska; J R Parnes; A M Schmitt-Verhulst; B Malissen
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

5.  Recognition of influenza-infected cells by cytolytic T lymphocyte clones: determinant selection by class I restriction elements.

Authors:  A Vitiello; L A Sherman
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

6.  Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.

Authors:  S L Swain; D P Dialynas; F W Fitch; M English
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

7.  HLA antigens expressed on murine cells are preferentially recognized by murine cytotoxic T cells in the context of the H-2 major histocompatibility complex.

Authors:  M J Holterman; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Expression and function of CD8 in a murine T cell hybridoma.

Authors:  S E Ratnofsky; A Peterson; J L Greenstein; S J Burakoff
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  32 in total

1.  Molecular cloning, reconstruction and expression of the gene encoding the alpha-chain of the bovine CD8--definition of three peptide regions conserved across species.

Authors:  P Lalor; C Bucci; M Fornaro; M C Rattazzi; H Nakauchi; L A Herzenberg; S Alberti
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

2.  Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.

Authors:  Zoltan Antal; Jason C Baker; Carla Smith; Irene Jarchum; Jeffrey Babad; Gayatri Mukherjee; Yang Yang; John Sidney; Alessandro Sette; Pere Santamaria; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

Review 3.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.

Authors:  Preeti Pancholi; Marion Perkus; Nancy Tricoche; Qingyan Liu; Alfred M Prince
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.

Authors:  Jo A Tucker; Caroline Jochems; Benjamin Boyerinas; Jonathan Fallon; John W Greiner; Claudia Palena; Timothy C Rodell; Jeffrey Schlom; Kwong-Yok Tsang
Journal:  Cancer Immunol Immunother       Date:  2014-09-04       Impact factor: 6.968

6.  Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Authors:  B Wizel; M Palmieri; C Mendoza; B Arana; J Sidney; A Sette; R Tarleton
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Specific tolerance across a discordant xenogeneic transplantation barrier.

Authors:  L A Lee; H A Gritsch; J J Sergio; J S Arn; R M Glaser; T Sablinski; D H Sachs; M Sykes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

9.  Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.

Authors:  Yanbo Lv; Zhihua Ruan; Li Wang; Bing Ni; Yuzhang Wu
Journal:  BMC Immunol       Date:  2009-12-03       Impact factor: 3.615

10.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.